Abiomed Inc (ABMD) - Product Pipeline Analysis, 2018 Update

  • ID: 4319044
  • Company Profile
  • 39 pages
  • GlobalData
  • Abiomed Inc
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • Edwards Lifesciences Corp
  • Getinge AB
  • Jarvik Heart Inc
  • Maquet Cardiovascular LLC
  • MORE
Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Abiomed Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • Edwards Lifesciences Corp
  • Getinge AB
  • Jarvik Heart Inc
  • Maquet Cardiovascular LLC
  • MORE
  • Abiomed Inc Company Overview
  • Abiomed Inc Company Snapshot
  • Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Abiomed Inc - Pipeline Analysis Overview
  • Business Description
  • Abiomed Inc - Key Facts
  • Abiomed Inc - Major Products and Services
  • Abiomed Inc Pipeline Products by Development Stage
  • Abiomed Inc Ongoing Clinical Trials by Trial Status
  • Abiomed Inc Pipeline Products Overview
  • AbioCor II
  • AbioCor II Product Overview
  • Impella BTR
  • Impella BTR Product Overview
  • Impella CP (Cardiac Power)
  • Impella CP (Cardiac Power) Product Overview
  • Impella CP (Cardiac Power) Clinical Trial
  • Impella ECP
  • Impella ECP Product Overview
  • Impella RP
  • Impella RP Product Overview
  • Impella RP Clinical Trial
  • Next Generation Impella CP - STEMI
  • Next Generation Impella CP - STEMI Product Overview
  • Next Generation Impella CP - STEMI Clinical Trial
  • Symphony Heart Pump
  • Symphony Heart Pump Product Overview
  • Abiomed Inc - Key Competitors
  • Abiomed Inc - Key Employees
  • Abiomed Inc - Key Employee Biographies
  • Abiomed Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Abiomed Inc, Recent Developments
  • May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year
  • Apr 12, 2018: First Patient Treated with High Energy Proton Therapy in UK
  • Apr 04, 2018: Abiomed Announces European Approval (CE Marking) for Impella 5.5 and First Patient Treated at University Heart Center Hamburg
  • Apr 02, 2018: Abiomed Receives FDA Approval for Impella CP with SmartAssist and Optical Sensor
  • Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
  • Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations
  • Feb 14, 2018: Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures
  • Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery
  • Feb 13, 2018: Atossa Genetics to Present at Adoptive T-Cell Therapy Symposium - Molecular Medicine Tri-Conference
  • Feb 13, 2018: Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Abiomed Inc Pipeline Products by Equipment Type
  • Abiomed Inc Pipeline Products by Indication
  • Abiomed Inc Ongoing Clinical Trials by Trial Status
  • Abiomed Inc, Key Facts
  • Abiomed Inc, Major Products and Services
  • Abiomed Inc Number of Pipeline Products by Development Stage
  • Abiomed Inc Pipeline Products Summary by Development Stage
  • Abiomed Inc Ongoing Clinical Trials by Trial Status
  • Abiomed Inc Ongoing Clinical Trials Summary
  • AbioCor II - Product Status
  • AbioCor II - Product Description
  • Impella BTR - Product Status
  • Impella BTR - Product Description
  • Impella CP (Cardiac Power) - Product Status
  • Impella CP (Cardiac Power) - Product Description
  • Impella CP (Cardiac Power) - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry
  • Impella CP (Cardiac Power) - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial
  • Impella CP (Cardiac Power) - Pulsecath mechanicaL Support Evaluation (PULSE) - Trial
  • Impella ECP - Product Status
  • Impella ECP - Product Description
  • Impella RP - Product Status
  • Impella RP - Product Description
  • Impella RP - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry
  • Next Generation Impella CP - STEMI - Product Status
  • Next Generation Impella CP - STEMI - Product Description
  • Next Generation Impella CP - STEMI - Door to Unloading with IMPELLA CP System in Acute Myocardial Infarction to Reduce Infarct Size (DTU): A Prospective Feasibility Study
  • Symphony Heart Pump - Product Status
  • Symphony Heart Pump - Product Description
  • Abiomed Inc, Key Employees
  • Abiomed Inc, Key Employee Biographies
  • Abiomed Inc, Subsidiaries
  • Glossary
List of Figures
  • Abiomed Inc Pipeline Products by Equipment Type
  • Abiomed Inc Pipeline Products by Development Stage
  • Abiomed Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories
  • Boston Scientific Corp
  • Edwards Lifesciences Corp
  • Getinge AB
  • HeartWare International Inc
  • Jarvik Heart Inc
  • Maquet Cardiovascular LLC
  • Medtronic Plc
  • TandemLife
  • Teleflex Inc
  • Terumo Heart, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll